BCL2 and ovarian carcinoma: It was also reported that miR-140 targeted BCL9 and BCL2 and prevented colorectal cancer progression, miR-148a targeted BCL2 in non-small cell lung cancer, and miR-340 decreased BCL2 and increased Bax to induce cell apoptosis in ovarian cancer [144].